Meprin β elevates hippocampal soluble Aβ in the APP/V717I mouse model.

Area of Science:

• Neuroscience
• Biochemistry
• Genetics

Background:

• Alzheimer's disease (AD) pathology involves amyloid-beta (Aβ) peptides, crucial for both familial and sporadic forms.
• Understanding Aβ generation is vital, with BACE1 traditionally studied, but it doesn't produce N-terminally truncated Aβ species prevalent in AD brains.
• Alternative proteases, like meprin β, are increasingly recognized for their role in APP processing and AD pathology.

Purpose of the Study:

• To develop a more accurate mouse model for Alzheimer's disease (AD) pathology beyond BACE1-overexpressing models.
• To investigate the role of meprin β in Amyloid Precursor Protein (APP) cleavage within the hippocampus and cerebral cortex.
• To assess the impact of meprin β overexpression on Aβ generation and potential behavioral deficits.

Main Methods:

• Development of a mouse model overexpressing meprin β.
• Biochemical analysis of soluble Aβ levels in hippocampal and cerebral cortex tissues.
• Assessment of behavioral deficits in the engineered mouse model.

Main Results:

• Overexpression of meprin β significantly increased soluble Aβ levels, with a pronounced effect in the hippocampus.
• Meprin β activity appears higher or the hippocampus shows greater vulnerability compared to the cerebral cortex.
• No observable behavioral deficits were detected in mice overexpressing meprin β, despite biochemical changes.

Conclusions:

• Meprin β plays a significant role in generating Aβ species relevant to Alzheimer's disease (AD) pathology.
• The hippocampus may be particularly susceptible to meprin β-mediated Aβ production.
• This study provides a novel mouse model for AD research, highlighting a region-specific role for meprin β that warrants further investigation beyond immediate behavioral impairment.